Eledon Pharmaceuticals, Inc. (ELDN)

NASDAQ: ELDN · Real-Time Price · USD

2.740

-0.240 (-8.05%)

At close: Oct 10, 2025, 4:00 PM EDT

2.750

+0.010 (0.36%)

After-hours: Oct 10, 2025, 7:48 PM EDT

Eledon Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2012 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2012 - 2019
Selling, General & Admin	19.65	18.61	12.69	12.7	13.13	10.05	Upgrade
Research & Development	68.26	51.96	30.31	27.08	23.74	6.13	Upgrade
Other Operating Expenses	-	-	-	48.65	-	2.28	Upgrade
Total Operating Expenses	87.9	70.58	43	88.43	36.87	18.47	Upgrade
Operating Income	-87.9	-70.58	-43	-88.43	-36.87	-18.47	Upgrade
Total Non-Operating Income (Expense)	102.98	34.82	-73.54	0.46	0.01	-4.75	Upgrade
Pretax Income	15.07	-35.75	-116.54	-87.97	-36.86	-23.22	Upgrade
Provision for Income Taxes	-	-0.43	-	-	2.35	0.4	Upgrade
Net Income	15.07	-35.32	-116.54	-87.97	-39.21	-23.62	Upgrade
Net Income to Common	15.07	-35.32	-116.54	-87.97	-39.21	-23.62	Upgrade
Shares Outstanding (Basic)	69	49	25	14	15	1	Upgrade
Shares Outstanding (Diluted)	69	49	25	14	15	1	Upgrade
Shares Change (YoY)	108.52%	97.18%	72.34%	-3.61%	921.03%	121.42%	Upgrade
EPS (Basic)	0.70	-0.66	-3.74	-6.16	-2.33	-15.72	Upgrade
EPS (Diluted)	0.70	-0.66	-3.74	-6.16	-2.33	-15.72	Upgrade
Free Cash Flow	-64.53	-47.27	-39.53	-28.42	-28.91	-15.21	Upgrade
Free Cash Flow Per Share	-0.93	-0.97	-1.61	-1.99	-1.95	-10.48	Upgrade
EBITDA	-87.9	-70.58	-43	-88.43	-36.87	-18.46	Upgrade
EBIT	-87.9	-70.58	-43	-88.43	-36.87	-18.47	Upgrade
Effective Tax Rate	0.00%	1.21%	0.00%	0.00%	-6.39%	-1.74%	Upgrade

Updated Aug 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q